Welcome to
Prosigna is 510(k) cleared and CE marked. Prosigna is available to healthcare professionals in the United States, in markets that recognize the CE mark, and/or in which Prosigna is registered.
I am a healthcare professional in the US
I am a healthcare professional outside the US
Home
This site is intended for US residents only.
Loading...
Managing patients with
early-stage breast cancer…
…begins with a highly
accurate assessment of risk
Mastering the science
of tumor biology
Prosigna uses the PAM50 gene
signature to translate tumor
biology into your patient's individualized
prognostic score.
Achieving precise results
Advanced technology generates precise,
reproducible prognostic information in
local qualified laboratories.
Proven risk assessment
you can trust
Prosigna reliably identifies
your patient's 10-year risk
of distant recurrence.
Proceed with confidence